ResMed Inc. (ASX: RMD)
28.38
+0.05 (0.18%)
Jul 3, 2024, 4:10 PM AEST
ResMed Revenue
ResMed had revenue of $4.43B USD in the twelve months ending March 31, 2024, with 10.37% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.20B USD with 7.17% year-over-year growth. In the fiscal year ending June 30, 2023, ResMed had annual revenue of $4.22B USD with 32.10% growth.
Revenue (ttm)
$4.43B
Revenue Growth
+10.37%
P/S Ratio
6.29
Revenue / Employee
$437,094
Employees
10,140
Market Cap
41.69B AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 4.22B | 1.03B | 32.10% |
Jun 30, 2022 | 3.20B | 239.81M | 8.11% |
Jun 30, 2021 | 2.96B | 350.44M | 13.44% |
Jun 30, 2020 | 2.61B | - | - |
Jun 30, 2019 | 2.61B | 266.38M | 11.38% |
Jun 30, 2018 | 2.34B | 273.46M | 13.23% |
Jun 30, 2017 | 2.07B | 228.02M | 12.40% |
Jun 30, 2016 | 1.84B | 159.80M | 9.52% |
Jun 30, 2015 | 1.68B | 123.94M | 7.97% |
Jun 30, 2014 | 1.55B | 40.52M | 2.68% |
Jun 30, 2013 | 1.51B | 145.94M | 10.66% |
Jun 30, 2012 | 1.37B | 125.37M | 10.08% |
Jun 30, 2011 | 1.24B | 150.79M | 13.80% |
Jun 30, 2010 | 1.09B | 171.62M | 18.64% |
Jun 30, 2009 | 920.74M | 85.34M | 10.22% |
Jun 30, 2008 | 835.40M | 119.07M | 16.62% |
Jun 30, 2007 | 716.33M | 109.34M | 18.01% |
Jun 30, 2006 | 607.00M | 181.49M | 42.65% |
Jun 30, 2005 | 425.51M | 86.17M | 25.39% |
Jun 30, 2004 | 339.34M | 65.77M | 24.04% |
Jun 30, 2003 | 273.57M | 69.49M | 34.05% |
Jun 30, 2002 | 204.08M | 48.92M | 31.53% |
Jun 30, 2001 | 155.16M | 39.54M | 34.20% |
Jun 30, 2000 | 115.62M | 27.02M | 30.49% |
Jun 30, 1999 | 88.60M | 22.10M | 33.23% |
Jun 30, 1998 | 66.50M | 17.30M | 35.16% |
Jun 30, 1997 | 49.20M | 14.60M | 42.20% |
Jun 30, 1996 | 34.60M | 11.10M | 47.23% |
Jun 30, 1995 | 23.50M | 9.60M | 69.06% |
Jun 30, 1994 | 13.90M | 6.20M | 80.52% |
Jun 30, 1993 | 7.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 31.79B |
Cochlear Limited | 2.18B |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Pro Medicus Limited | 142.12M |
Sonic Healthcare Limited | 8.21B |
Ramsay Health Care Limited | 15.96B |
Telix Pharmaceuticals Limited | 502.55M |
Neuren Pharmaceuticals Limited | 231.93M |
ResMed News
- 1 day ago - Why Investors Are Eyeing ResMed Inc (RMD): The Key Drivers of Market Outperformance and Growth ... - GuruFocus
- 4 days ago - This Is What Whales Are Betting On ResMed - Benzinga
- 5 days ago - ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. - Barrons
- 7 days ago - ResMed cut at Oppenheimer after Eli Lilly’s tirzepatide sleep apnea data - Seeking Alpha
- 8 days ago - Inspire Medical, ResMed decline following Lilly tirzepatide sleep apnea data - Seeking Alpha
- 8 days ago - Why ResMed Shares Are Trading Lower Monday - Benzinga
- 8 days ago - ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday - Benzinga
- 8 days ago - ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday - Benzinga